Transplantation of Allogenic Fetal Membrane-Derived Mesenchymal Stem Cells Protects against Ischemia/Reperfusion-Induced Acute Kidney Injury

Transplantation of Allogenic Fetal Membrane-Derived Mesenchymal Stem Cells Protects against Ischemia/Reperfusion-Induced Acute Kidney Injury

Mesenchymal stem cells (MSCs) are an attractive therapeutic cell source for treating renal diseases. MSC administration has been shown to improve renal function, although the underlying mechanisms are not completely understood. We recently showed that allogenic fetal membrane-derived MSCs (FM-MSCs),...

Full description

Bibliographic Details
Main Authors: Hidetoshi Tsuda, Kenichi Yamahara, Kentaro Otani, Masayoshi Okumi, Koji Yazawa, Jun-Ya Kaimori, Akihiko Taguchi, Kenji Kangawa, Tomoaki Ikeda, Shiro Takahara, Yoshitaka Isaka M.D., Ph.D.
Format: Article
Language:English
Published: SAGE Publishing 2014-07-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368913X665594

Internet

https://doi.org/10.3727/096368913X665594

Similar Items